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ABSTRACT 
OBJECTIVE The natural history and long-term durability of Guglielmi detachable coil (GDC) 
embolization is still unknown. We hypothesize a stepwise decrease in durability of embolized 
cerebral aneurysms as stratified by the modified Raymond Roy Classification (MRRC). 
METHODS First-time GDC embolized cerebral aneurysms were retrospectively reviewed from 
2004 to 2015. Loss of durability (LOD) was defined by change in aneurysm size or patency seen 
on serial radiographic follow-up. Kaplan-Meier survival analysis was performed to evaluate 
embolization durability. Multivariate Cox Regression Modeling was used to assess baseline 
aneurysm and patient characteristics for their effect on LOD.  
RESULTS There were 427 patients with 443 aneurysms who met inclusion criteria. Overall, 89 
(21%) aneurysms met LOD criteria. Grade 1 aneurysms had statistically significantly greater 
durability than all other MRRC grades. Grade 3b aneurysms had significantly worse durability 
than all other aneurysm grades. There was no difference in durability between grade 2 and 3a 
aneurysms. Of aneurysms with LOD, 26 (29%) experienced worsening of MRRC grade. 
Interestingly, 35 (24%) initial MRRC grade 2, 72 (45%) initial MRRC grade 3a, and 6 (22%) 
initial MRRC grade 3b aneurysms progressed to MRRC grade 1 without retreatment. In our 
multivariate analysis, only initial MRRC grade was statistically significantly associated with 
treatment durability (p<0.001).  
CONCLUSIONS MRRC grade is independently associated with first-time GDC embolized 
cerebral aneurysm durability. Achieving MRRC grade 1 occlusion outcome is significantly 
associated with greater long-term GDC durability. Although few aneurysms experience further 
growth and/or recanalization, a majority of incompletely obliterated aneurysms tend to remain 
stable over time or even progress to occlusion. Grading scales such as the MRRC are useful for 
characterizing aneurysm occlusion but may lack sensitivity and specificity for characterizing 
changes in aneurysm morphology over time.   
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INTRODUCTION 
 
The prevalence of unruptured intracranial aneurysms (IAs) is approximately 3.2% in the general 
population. Women are nearly twice as likely to have an aneurysm compared to men.1 The 
approximate age- and sex-adjusted annual incidence of subarachnoid hemorrhage is 10 per 
100,000.2 IA rupture is a major source of neurologic morbidity and mortality.3,4,5 Conventional 
treatment options for IAs include surgical clipping across the neck of the aneurysm and 
endovascular therapy, originally with the use of Guglielmi detachable coils (GDCs) and with 
subsequent innovations including balloon-assisted coil embolization, stent-assisted coil 
embolization, and stent-only treatment with flow diversion. While elective aneurysms are 
increasingly being treated with stent-assisted coiling and more recently with flow diversion, 
there nevertheless remains a large population of unruptured aneurysms treated with coil 
embolization only and the vast majority of ruptured aneurysms are treated with coil 
embolization.6 
 
Since the invention of the GDC, endovascular treatment techniques and management guidelines 
for IAs have continually evolved.7,8 The question of the preferred treatment strategy for 
unruptured IAs remains uncertain. There have been two major randomized controlled trials 
comparing endovascular coiling with surgical clipping of ruptured aneurysms, namely The 
International Subarachnoid Aneurysm Trial (ISAT)9 and the Barrow Ruptured Aneurysm Trial 
(BRAT).10 While there was no difference in the recurrent hemorrhage rate of aneurysms 
undergoing endovascular and surgical treatment in the BRAT trial, there was a statistically 
significant increase in retreatment of coiled patients at both the 3-year 11 and 6-year 12 follow-up 
time points.   
 
Likewise, patients undergoing endovascular coiling in the ISAT trial were statistically 
significantly more likely to require retreatment and to experience a recurrent hemorrhage 
compared to patients treated with microsurgical clipping.13,14 These studies, and others, have 
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brought the durability of endovascular coiling into question.14, 15,16Additionally, aneurysm 
remnants are common after cerebral aneurysm coiling. A recent report utilizing ISAT data 
showed that 34% of coiled cerebral aneurysms had associated remnants.14 Predicting which IAs 
will remain stable after initial endovascular coiling remains a challenge for neuroendovascular 
surgeons.   
 
The Raymond Roy Occlusion Classification Scale is an angiographic classification scheme for 
grading occlusion of coiled cerebral aneurysms.17,18 Mascitelli et al.19 expanded the classification 
to differentiate class 3 aneurysms into those that will completely occlude versus those that will 
not, thereby in the author’s appraisal requiring further treatment. Their study focused on class 3 
aneurysms only but showed the potential for the Modified Raymond Roy Classification (MRRC) 
to stratify patients with residual aneurysms into those at higher and lower risk for recurrence.19  
 
The objective of our study is two-fold: 1) to characterize the natural history of first time coiled 
cerebral aneurysms, and 2) to identify risk factors associated with poor GDC durability. We 
hypothesize a stepwise decrease in durability of first time GDC-embolized cerebral aneurysms as 
stratified by the MRRC. 
 
METHODS 
Patient Selection 
This retrospective study was approved by the Indiana University School of Medicine 
Institutional Review Board. Subject inclusion criteria included 1) first time GDC embolization 
(all coiling techniques) of saccular cerebral aneurysm, ruptured or unruptured; 2) age greater 
than 18 years old; 3) at least 6 months of radiographic follow-up; and 4) treatment performed 
between 2004 and 2015. Subjects were excluded if they had any of the following: 1) fusiform 
aneurysm architecture as well as traumatic or mycotic aneurysm etiology; 2) association with 
arteriovenous malformation; 3) association with a malignant brain tumor, and 4) previous 
endovascular or surgical treatment. Patient demographics, clinical presentation, treatment 
characteristics, and radiographic follow-up were assessed for each case.  
 
Angiographic Review 
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All initial and follow-up angiography was retrospectively reviewed. Initial arterial imaging was 
always performed with digital subtraction angiography (DSA). Follow-up angiography consisted 
of DSA and/or magnetic resonance angiography (MRA). Although the angiographic review was 
not blinded, the initial angiogram was always evaluated before the follow-up to reduce bias. All 
aneurysms were graded using the Modified Raymond Roy Classification.18,19 Aneurysms were 
graded in at least two angiographic views. Aneurysms were classified as follows: Grade 1 - 
complete occlusion of aneurysm lumen and neck; Grade 2 - complete occlusion of aneurysm 
lumen with residual neck; Grade 3a - residual flow within the aneurysm but within the confines 
of the coil mass; Grade 3b - residual contrast opacification though a portion of the aneurysm 
neck with continuation along the aneurysm wall.  
 
Aneurysm size classification was based on the International Study of Unruptured Intracranial 
Aneurysms definition.20 The maximum aneurysm dome diameter was measured on initial 
preoperative angiogram and categorized as less than 7 mm, 7-12 mm, 13-24 mm, or greater than 
25 mm.  
  
Defining Loss of Durability   
At our institution, all patients with endovascularly treated aneurysms receive serial DSA and/or 
MRA to evaluate treatment durability. For each patient, all follow-up imaging was assessed for 
dynamic changes in post-treatment aneurysm morphology as well as change in MRRC grade. 
Loss of durability (LOD) was defined by change in aneurysm size or patency discovered on 
serial radiographic follow-up and included 1) aneurysm re-rupture, 2) aneurysm recanalization, 
and 3) remnant aneurysm enlargement. The authors believe that these factors are signs of 
aneurysm instability.  
 
 
 
Statistical Analysis 
The MRRC was calculated for each aneurysm on pretreatment DSA as described previously. 
Kaplan Meier curves were created to graphically depict time to aneurysm LOD based on MRRC. 
The log-rank test was used to identify any statistical differences between the constructed Kaplan 
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Meier curves. Baseline patient, aneurysm, and treatment characteristic effects on coil durability 
were evaluated using multivariate Cox Regression analysis. Intraoperative complications and 
admission neurologic complications were assessed for differences between MRRC groups using 
the Pearson χ2 test. All statistical analysis was performed using SPSS V.24.0 (IBM, Armonk, 
New York, USA).  
 
RESULTS 
Baseline Patient, Aneurysm, and Treatment Characteristics 
From 2004 to 2015, 718 consecutive patients with 740 first time coil-embolized cerebral 
aneurysms were identified. Sixty-four patients (9%) died during their initial hospitalization from 
sequela of subarachnoid hemorrhage. Of the remaining 654 patients, 427 (65%) had radiographic 
follow-up greater than 6 months. Mean (SD) patient age at treatment was 56.0 (10.7) years. Most 
patients were female (75.5%). Mean (SD) follow-up was 36 (30) months.  
 
The cohort was divided nearly in half for ruptured vs. unruptured aneurysm presentation (48.3% 
vs. 51.7%, respectively). Aneurysm size distribution was as follows: < 7 mm, 191 (43.2%); 7-12 
mm, 215 (48.5%); 13-24 mm, 29 (6.5%); and > 25 mm, 8 (1.8%). There were 294 aneurysms 
(66.4%) in the anterior circulation. Most aneurysms were treated with coil embolization alone 
(76.8%). Stent assist and balloon assist was performed in 20.3% and 2.9%, respectively (Table 
1). 
 
Change in MRRC Over Time 
Immediate post-treatment MRRC grade 1 (n = 114) aneurysms at the time of last follow-up or 
time of retreatment were reclassified as follows: grade 1, n = 105 (92%); grade 2, n = 5 (4%); 
grade 3a, n = 1 (1%); grade 3b, n = 3 (3%). Immediate post-treatment MRRC grade 2 (n = 143) 
aneurysms at the time of last follow-up or time of retreatment were reclassified as follows: grade 
1, n = 35 (24%); grade 2, n = 98 (69%); grade 3a, n = 2 (1%); grade 3b, n = 8 (6%).  
 
Immediate post-treatment MRRC grade 3a (n = 159) aneurysms at the time of last follow-up or 
time of retreatment were reclassified as follows: grade 1, n = 72 (45%); grade 2, n = 67 (42%); 
grade 3a, n = 13 (8%); grade 3b, n = 7 (5%). Immediate post-treatment MRRC grade 3b (n = 27) 
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aneurysms at the time of last follow-up or time of retreatment were reclassified as follows: grade 
1, n = 6 (22%); grade 2, n = 14 (52%); grade 3a, n = 1 (4%); grade 3b, n = 6 (22%) (Figure 1). 
 
Loss of Durability 
Overall, 89 (21%) aneurysms met LOD criteria. Two (2%) patients experienced post-treatment 
aneurysm rupture (both with hemorrhage at presentation), 15 (17%) experienced aneurysm 
enlargement, and 72 (81%) experienced recanalization. Nine MRRC grade 1 aneurysms 
experienced LOD at time of retreatment as follows: grade 1, n = 0 (0%); grade 2, n = 5 (56%); 
grade 3a, n = 1 (11%); grade 3b, n = 3 (33%). Thirty-two MRRC grade 2 aneurysms experienced 
LOD at time of retreatment as follows: grade,1 n = 0 (0%); grade 2, n = 22 (69%); grade 3a, n = 
2 (6%); grade 3b, n = 8 (25%). Thirty-six MRRC grade 3a aneurysms experienced LOD at time 
of retreatment as follows: grade 1, n = 0 (0%); grade 2, n = 22 (62%); grade 3a, n = 7 (19%); 
grade 3b, n = 7 (19%). Twelve MRRC grade 3b aneurysms experienced LOD at time of 
retreatment as follows: grade 1, n = 0 (0%); grade 2, n = 6 (50%); grade 3a, n = 0 (%); grade 3b, 
n = 6 (50%) (FIGURE 2). Overall, 26 (29%) aneurysms experienced worsening of MRRC grade 
with associated LOD.  
 
Kaplan Meier Analysis 
Mean (SD) time to LOD for grade 1, 2, 3a, and 3b aneurysms was 99 (6), 106 (6), 104 (6), and 
57 (10) months, respectively. Grade 1 aneurysms were found to have statistically significantly 
greater durability than grade 2 (p = 0.002), 3a (p = 0.003), and 3b (p < 0.001) aneurysms. Grade 
3b aneurysms had significantly worse durability than all other aneurysm grades (p < 0.015). 
There was no difference in durability between grade 2 and 3a aneurysms (p = 0.845). Estimated 
long-term cumulative durability (SD) at 10 years for grade 1, 2, 3a, and 3b aneurysms was 76.9 
(1.0), 70.9 (4.6), 67.5 (5.7), and 47.2 (10.8) percent, respectively (FIGURE 3).  
 
 
Cox Regression Analysis 
Multivariate Cox Regression analysis revealed that only MRRC is statistically significantly 
associated with aneurysm durability (p = 0.001). All MRRC grades when compared to MRRC 
grade 1 portend significantly worse durability (Table 2). Specifically, the following variables did 
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not significantly affect aneurysm treatment durability in our multivariate analysis: age (p = 
0.500), sex (p = 0.298), smoker (p = 0.379), hypertension (p = 0.106), ruptured (p = 0.158), 
anterior vs. posterior circulation (p = 0.847), aneurysm size (0.074), and aneurysm treatment type 
(p = 0.773) (Table 2).  
 
Complications and Clinical Outcome  
There was no statistically significant difference in intraoperative complications between MRRC 
groups: rupture (p = 0.911), coil migration (p = 0.408), parent vessel compromise (p = 0.237), 
dissection (p = 1.00), thromboembolic event (p = 0.761), and femoral artery injury (p = 1.000). 
There was no statistically significant difference between MRRC groups for development of new 
hydrocephalus (p = 0.479), need for external ventricular drain placement (p = 0.882), need for 
ventriculoperitoneal shunt placement (p = 0.420), development of vasospasm (p = 0.807), new 
ischemic stroke (p = 0.896), or new intracranial hemorrhage (p = 0.683).  
 
Across MRRC groups there was a statistically significant difference in new neurologic deficit (p 
= 0.008).  A significant difference in new neurologic deficits was found between MRRC grade 1 
and 3b (p = 0.0024). MRRC grade 1 aneurysm patients were statistically significantly less likely 
to have a new neurologic deficit post treatment. There was a trend toward greater neurologic 
deficits between MRRC grade 3b and grades 2 and 3a (p = 0.0523 and p = 0.0587, respectively). 
MRRC grade 2 and 3a aneurysm patients were less likely to have a new neurologic deficit post 
treatment, although this did not reach statistical significance.  There was a trend toward 
significantly different mortality rates across MRRC groups, but this did not reach statistical 
significance (p = 0.057) (Table 3).  
 
DISCUSSION  
The natural history of coiled cerebral aneurysms remains debated.  There is a large body of 
literature describing rates of aneurysm recurrence, retreatment, and re-bleeding but there is a 
paucity of data on long-term coil stability. In our study, we defined loss of durability as dynamic 
change in aneurysm morphology (i.e., aneurysm growth or interval increase in aneurysm 
patency) because it identifies aneurysms that are thought to require, by a high-volume tertiary 
care academic practice, additional treatment. While this metric on the one hand is dependent on 
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radiographic interpretation, it may very well also represent the most objective endpoint for a 
treated aneurysm apart from (re)rupture.   
 
This standard categorizes aneurysm coil durability into reproducible subsets; the aneurysm is 
either unchanged (or less patent) from the original coiling or it is more patent.  This standard, 
however, reflects only coil durability and not aneurysm stability.  There may very well be small 
post-coil aneurysm remnants which remain unchanged on follow-up imaging but which can 
(re)rupture.  In the end, the most objective system for evaluating aneurysm treatment is one that 
dichotomizes between cure versus non-cure.21 
 
Evaluating aneurysm coil durability by morphologic change versus MRRC eliminates 
estimations of whether aneurysm patency extends to the saccular wall and does not rely on a 
somewhat arbitrary distinction between aneurysm neck and dome. The MRRC is limited to 
categorizing variations in filling only if the aneurysm can be reclassified as a different grade, i.e., 
if the dome versus the neck becomes patent or if the patent portion of the aneurysm extends to 
the saccular wall.   
 
In our study, aneurysms were stratified by the MRRC because it is a well-known grading system 
commonly used to evaluate treatment outcome after cerebral aneurysm coiling. The MRRC 
grading system proved to be far less sensitive to changes thought by our neurovascular treatment 
group to be clinically significant than examining more subtle differences in patency. For 
example, seven aneurysms initially graded MRRC 3a remained grade 3a at the time of 
retreatment. They were retreated for subtle coil compaction and increased filling within the coil 
mass, not because of a change in MRRC grade. In the era of flow diversion in which true cure is 
an achievable goal for all aneurysms, this more sensitive evaluation system may reflect a more 
appropriate standard in evaluating for retreatment. 
 
Changes in post-treatment aneurysm morphology over time after coiling is not well-documented 
in the scientific literature. Hayakawa et al.22 described the natural history of the neck remnant 
shortly after popularization of coiling. They concluded that small aneurysms with small necks 
were able to be definitively treated with GDCs however, large or giant aneurysms with wide 
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necks experienced a high rate of recanalization.18 To the authors knowledge, this is the only 
study that has examined GDC coil durability over time. While this study provides a framework 
for understanding factors associated with recanalization of neck remnants, it fails to address 
recanalization of MRRC type 3a and 3b remnants. Additionally, this study was underpowered to 
statistically identify factors independently associated with aneurysm loss of durability.   
 
Our study examines post-treatment changes based on both MRRC and our more sensitive 
patency estimation through serial radiographic imaging.  Initial MRRC grade 1 aneurysms tend 
to be the most stable over time, though aneurysms in each baseline MRRC grade tended to stay 
the same or improve.  The implication of this radiographic improvement in persistently patent 
aneurysms has however not been demonstrated; i.e. until an aneurysm is cured, there is some risk 
of rupture and that risk may or may not be affected by decreased post-treatment aneurysm 
patency. In our experience, 89 (21%) aneurysms experienced LOD on serial imaging.  This is in 
line with published recanalization rates.23 Interestingly, only 26 (6%) of these aneurysms had 
associated changes in MRRC highlighting the increased sensitivity of a standard that utilizes 
increased patency following coiling versus change in MRRC categories.  
 
Twenty-two (69%) grade 2 aneurysms experiencing LOD, had further coil compaction and 
remnant recanalization at the neck but without changes in MRRC grading (FIGURE 4).  
Similarly, 22 (62%) grade 3a aneurysms experiencing LOD had decreased patency and reversion 
to grade 2, but subsequently demonstrated recanalization at the neck (FIGURE 5).   
 
To our knowledge, no studies have directly compared durability across all four MRRC 
groups.18,22,24,25-29 In our study, grade 1, 2, and 3a aneurysms had similar mean time to LOD – 
approximately 100 months (8.3 years). Class 3b aneurysms had a significantly shorter time to 
LOD - 57 months (4.75 years). Kaplan Meier analysis demonstrated a step-wise decrease in 
aneurysm durability across MRRC grades (FIGURE 1). As hypothesized, we demonstrated a 
statistically significant stepwise decrease in LOD across MRRC grades - LOD grade 3b > grade 
3a = grade 2 > grade 1.  
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Risk factors for aneurysm recurrence have been studied extensively. Incomplete aneurysm 
occlusion/recurrence leads to further interventional procedures and carries risk for aneurysm re-
rupture. Prior studies have identified aneurysm size, 23,27,30,31-33 neck diameter,27,32,34 packing 
density, 23,30,35,36 rupture status, 2,23,32,33 aneurysm location, 23,37 patient age, 30,36,37 and incomplete 
initial occlusion 27,32 as factors associated with aneurysm recurrence. Our study, although limited 
by its retrospective nature, is representative of a typical large volume academic aneurysm 
treatment center.  
 
In our multivariate survival analysis, only MRRC grade was statistically significantly associated 
with aneurysm retreatment. Age, sex, smoking status, hypertension, rupture status, location, 
aneurysm size, and aneurysm treatment had no effect on coil durability. Our results indicate that 
immediate post coiling MRRC grade is the single most important factor in predicting coil 
occlusion longevity.  
 
An interesting observation in our study was that incompletely treated aneurysms can progress to 
complete occlusion over time. In fact, in our study this occurrence was more common than LOD. 
Overall, 113 (34%) of all aneurysms that were not initially MRRC grade 1 progressed to 
complete occlusion over time without retreatment. MRRC grade 3a aneurysms were most likely 
to progress to complete occlusion. This finding demonstrates the need for close aneurysm 
follow-up. Treatment is warranted for changes in aneurysm morphology, not for persistent filling 
without changes in flow dynamics.  
 
The most common complications following endovascular coiling of cerebral aneurysms are 
thromboembolic with a frequency of 2.4 to 10% in the literature.38-41 In our series this occurred 
in 16 (3.7%) of patients. Of these patients, 11 (69%) suffered from an infarct on follow-up MRI. 
One patient developed ischemic stroke due to parent vessel compromise.  Intraoperative rupture 
is another frequently cited complication occurring in 0 to 8% of studies.15,42-45 In our series, this 
occurred in 4 (1%) of the patients. No patient died or suffered permanent neurologic deficit as a 
direct result of intraoperative rupture.  Mortality from coiling procedures ranges from 0 to 2% in 
the literature.41,42,46 In our cohort, 6 (1.4%) patients died, but no deaths were recorded in the 
immediate perioperative period. There was no statistically significant difference in intraoperative 
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complications across different MRRC groups. MRRC 3b aneurysms had statistically greater 
chance of new neurologic deficits than the MRRC group 1. Two grade 1 patients experienced 
new neurologic deficits – both due to vasospasm after coiling and consequences of subarachnoid 
hemorrhage. Four grade 3b patients experienced new neurologic deficits – two patients 
experienced vasospasm after coiling, one patient developed hemiparesis and ischemic stroke 
symptoms, and one patient developed double vision after coiling. All new neurologic deficits in 
both groups resolved by the time of last follow-up. 
 
This study has a number of limitations. It is a retrospective study which inherently introduces 
bias. The study spanned a 12-year period during which significant innovation in the endovascular 
technologies occurred. The number of patients lacking long-term follow-up that were unable to 
be included in our study is also a potential source of selection bias that cannot be ignored. The 
subjective nature of the angiographic grading system is an additional shortcoming. Although the 
Raymond Roy Classification system is widely accepted, it has not been prospectively validated 
for intra- and inter-observer reliability. Lastly, this is a single center study and therefore our 
results may not be generalizable.  
 
 
 
CONCLUSIONS 
MRRC grade is independently associated with durability of coil occlusion among the first time 
GDC-embolized cerebral aneurysms. Achieving MRRC grade 1 occlusion outcome is 
significantly associated with greater long-term coil durability, particularly as compared with 
grade 3b occlusion. Although few aneurysms experience further growth and/or recanalization, it 
appears that a majority of incompletely obliterated aneurysms tend to remain stable and/or 
occlude over time. Grading scales such as the MRRC are useful for characterizing aneurysm 
occlusion but appear to lack sensitivity and specificity for characterizing more sensitive changes 
in aneurysm morphology over time.  
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FIGURE LEGENDS 
 
FIGURE 1 – Immediate post-treatment modified Raymond Roy Classification (MRRC) grade 
(Black) versus last follow-up MRRC Grade or MRRC Grade at loss of durability (Grey). 
 
FIGURE 2 – Immediate post-treatment modified Raymond Roy Classification (MRRC) grade 
(Black) for aneurysms experiencing LOD versus Grade at loss of durability (Grey). 
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FIGURE 3. Kaplan Meier Time to Loss of Durability Curve stratified by Modified Raymond 
Roy Classification Grading. 
 
FIGURE 4.  A: Initial angiogram demonstrating a 12-mm anterior communicating artery 
aneurysm on right internal carotid artery injection. B: Post-coiling angiogram demonstrating 
modified Raymond Roy Classification (MRRC) Grade 2 remnant. C: 6-month post-treatment 
MRA demonstrating enlargement of base remnant. D: Follow-up angiogram after MRA evidence 
of base recanalization demonstrating clear evidence of coil compaction with base enlargement 
but grade remains MRRC 2. E: Retreatment of base recurrence. F: Final outcome after 
retreatment demonstrating MRRC Grade 3a.   
 
FIGURE 5. A: Initial angiogram demonstrating a 17mm basilar apex aneurysm. B: Post-coiling 
angiogram demonstrating MRRC Grade 3 remnant (note filling within the coil mass), C: 1-
month post-treatment angiogram demonstrating MRRC Grade 2 with significant coil-compaction 
at the base of the aneurysm: D: Post-retreatment angiogram demonstrating MRRC Grade 1 
result. E: 6-month post-retreatment MRA demonstrating coil compaction at the base resulting in 
MRRC Grade 2. F: 12-month Post-retreatment MRA demonstrating stability of MRRC Grade 2 
aneurysm.  
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TABLE 1 - Baseline Patient, Aneurysm, and Treatment Characteristics. 
 
Patient Demographics   
Patients, n 427 
Aneurysms, n 443 
Age, mean(SD), y 56.0 (10.7) 
Female, n (%) 330 (75.5) 
Smoker, n (%) 287 (64.7) 
Hypertension, n (%) 237 (53.4) 
Aneurysm Retreatment 89 (20.1) 
Modified Raymond Roy Treatment Grade 
1, n (%) 114 (25.7) 
2, n (%) 143 (32.3) 
3a, n (%) 159 (35.9) 
3b, n (%) 27 (6.1) 
Rupture Status   
Ruptured, n (%) 214 (48.3) 
Unruptured, n (%) 229 (51.7) 
▸ Symptomatic, n (%) 48 (21.0) 
Aneurysm Size (mm)   
< 7, n (%) 191 (43.2) 
7-12, n (%) 215 (48.5) 
13-24, n (%) 29 (6.5) 
>25, n (%) 8 (1.8) 
Aneurysm Location   
Anterior Circulation, n (%) 294 (66.4) 
▸ Anterior communicating, n (%) 97 (21.9) 
▸ Posterior communicating, n (%) 59 (13.3) 
▸ Ophthalmic, n (%) 49 (11.1) 
▸ ICA bifurcation, n (%) 16 (3.6) 
▸ Pericallosal, n (%) 14 (3.2) 
▸ MCA, n (%) 14 (3.2) 
▸ Cavernous ICA, n (%) 12 (2.7) 
▸ ICA paraclinoid, n (%) 12 (2.7) 
▸ Superior hypophyseal, n (%) 11 (2.5) 
▸ Anterior choroidal, n (%) 5 (1.1) 
▸ ACA other, n (%) 3 (0.7) 
▸ ICA other, n (%) 2 (0.5) 
Posterior Circulation, n (%) 149 (33.6) 
▸ Basilar tip, n (%) 102 (23.0) 
▸ Basilar trunk, n (%) 16 (3.6) 
▸ SCA, n (%) 11 (2.5) 
▸ PCA, n (%) 9 (2.0) 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
▸ PICA, n (%) 7 (1.6) 
▸ Vertebral, n (%) 2 (0.5) 
▸ AICA, n (%) 1 (0.2) 
▸ Basilar Fenestration, n (%) 1 (0.2) 
Procedure Assistance   
Stand-alone, n (%) 340 (76.8) 
Stent assist, n (%) 90 (20.3) 
Balloon assist, n (%) 13 (2.9) 
 
 
ICA = Internal Carotid Artery; MCA= Middle Cerebral Artery; ACA = Anterior Cerebral Artery; 
SCA = Superior Cerebellar Artery; PCA = Posterior Cerebral Artery; PICA= Posterior Inferior 
Cerebellar Artery; AICA = Anterior Inferior Cerebellar Artery 
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Table 2. Multivariate Cox Regression Analysis of Variables associated with Aneurysm 
Treatment Durability  
 
 
 Sig. Exp(B) 
95.0% CI for 
Exp(B) 
Lower Upper 
Age .500 .992 .970 1.015 
Sex .298 .779 .487 1.247 
Smoker .379 .808 .502 1.300 
Hypertension .106 .690 .440 1.081 
Ruptured .158 .713 .445 1.141 
Anterior vs. Posterior 
Circulation 
.847 1.045 .667 1.639 
     
Aneurysm Size     
< 7 mm (Reference) .074    
7–12 mm .161 .410 .118 1.427 
13–24 mm .592 .718 .213 2.415 
> 25 mm .977 .980 .259 3.713 
     
Aneurysm Treatment     
Coil only (Reference) .773    
Stent assist .910 .940 .323 2.737 
Balloon assist .631 .752 .234 2.411 
     
Raymond Roy Classification     
Grade 1 (Reference) .001    
Grade 2 .000 .166 .069 .399 
Grade 3a .050 .505 .255 .999 
Grade 3b .026 .466 .238 .912 
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Table 3. Complications Stratified by Modified Raymond Roy Classification Grade. Across 
Group Comparisons Evaluated by Chi-Squared Statistical Method  
 
Modified Raymond Roy Classification Grade   
1 2 3a 3b  
p 
value 
Intraoperative Complications           
Rupture, n (%) 1 (0.8) 1 (0.7) 2 (1.3) 0 (0) 0.911 
Coil Migration, n (%) 1 (0.8) 0 (0) 0 (0) 0 (0) 0.408 
Parent Vessel Compromise, n (%) 5 (4.4) 4 (2.8) 1 (0.6) 1 (3.7) 0.237 
Dissection, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 1.000 
Thromboembolic Event, n (%) 4 (3.5) 6 (4.2) 6 (3.8) 0 (0) 0.761 
Femoral Artery Injury, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 1.000 
Admission Neurologic Complications           
Hydrocephalus, n (%) 14 (12.3) 14 (10.0) 25 (15.7) 3 (11.1) 0.479 
External Ventricular Drain Placement, n (%) 22 (19.3) 25 (17.5) 7 (4.4) 6 (22.2) 0.882 
Ventriculoperitoneal Shunt Placement, n (%) 11 (9.6) 13 (9.1 13 (8.2) 0 (0) 0.420 
Vasospasm, n (%) 18 (15.8) 19 (13.3) 19 (11.9) 3 (11.1) 0.807 
Ischemic Stroke, n (%) 4 (3.5) 3 (2.1) 4 (2.5) 1 (3.7) 0.896 
Hemorrhage, n (%) 1 (0.8) 1 (0.7) 0 (0) 0 (0) 0.683 
New Neurologic Deficit, n (%) 2 (1.8) 5 (3.5) 6 (3.8) 4 (14.8) 0.008 
Death, n (%) 1 (0.8) 5 (3.5) 0 (0) 0 (0) 0.057 
Aneurysm Loss of Durability, n (%) 9 (7.9) 32 (22.4) 36 (22.6) 12 (44.4) <0.001 
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Abbreviations 
 
Guglielmi detachable coil = GDC 
 
Loss of durability = LOD 
 
modified Raymond Roy Classification = MRRC 
intracranial aneurysms = IA 
 
International Subarachnoid Aneurysm Trial = ISAT 
 
Barrow Ruptured Aneurysm Trial = BRAT 
 
digital subtraction angiography = DSA 
